SCHEMBL1672869

SCHEMBL1672869

O=C(OCc1ccc(OC(F)(F)F)cc1)ON1CCN(CC[S+]([O-])c2ccc3nn[nH]c3c2)CC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 9/20 0.38
DGAT2 Q96PD7 1/20 0.38
ATXN2 Q99700 8/20 0.34
DRD3 P35462 1/20 0.34
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
CHRM1 P11229 1/20 0.32
ALDH1A1 P00352 2/20 0.32
GPR183 P32249 1/20 0.32
HRH2 P25021 1/20 0.31
HRH1 P35367 1/20 0.31
MCHR1 Q99705 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PANK3 Q9H999 1/20 0.31
GLP1R P43220 1/20 0.30
MAPK8 P45983 1/20 0.30
MAPK10 P53779 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1670770 0.89 PDE5A (0.33)
SCHEMBL11899245 0.89 ENPP2 (0.44) ENPP2DGAT2ATXN2DRD3ALDH1A1
SCHEMBL11898882 0.89 ENPP2 (0.44) ENPP2DGAT2ATXN2DRD3ALDH1A1
SCHEMBL1670653 0.88
SCHEMBL1671516 0.87 ENPP2 (0.35) ENPP2ATXN2
SCHEMBL1670737 0.86 MGLL (0.34)
SCHEMBL1670824 0.86 GPR183 (0.32) GPR183
SCHEMBL17888827 0.85 ENPP2 (0.40) ENPP2ATXN2
SCHEMBL11962603 0.83 ENPP2 (0.38) ENPP2DGAT2ATXN2ALDH1A1HRH2
SCHEMBL11962574 0.79 ENPP2 (0.44) ENPP2ATXN2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488504-B1 SULFOXIDE DERIVATIVES FOR TREATING TUMORS MERCK PATENT GMBH (DE) 2016-07-06 EP disclosed
EP-2488504-A1 SULFOXIDE DERIVATIVES FOR TREATING TUMORS Merck Patent GmbH (DE) 2012-08-22 EP disclosed
WO-2011044978-A1 SULFOXIDE DERIVATIVES FOR TREATING TUMORS MERCK PATENT GMBH (DE) 2011-04-21 WO disclosed